A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50.

Participants who engaged in 8-hour time-restricted eating, whether they ate early or late in the day, successfully lost ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Explainer-Who Qualifies for Medicare's New $50 Weight-Loss Drug Program and What Are the Concerns? By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected ⁠to ⁠gain ...

Starting Wednesday, people on Medicare will be able to get weight loss drugs, including Wegovy and Zepbound, for $50 a month. But patients hoping for quick or permanent access to the drugs may be ...

Medicare is starting to cover weight-loss drugs for some seniors. Starting this Wednesday, the Centers for Medicare & Medicaid Services (CMS) will now offer eligible Medicare recipients access to ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1. Mary Abrahamson hopes to be one of them. The rural ...

A new program for adults with Medicare Part D will cut the price of Wegovy, Zepbound, and Foundayo. Here’s how to know if you qualify. A new Medicare GLP-1 Bridge program will offer select weight loss ...

Syracuse, NY -- A new Medicare pilot program will launch July 1 that will offer affordable weight-loss drugs to millions of Americans. The GLP-1 Bridge program will allow Medicare recipients with Part ...

Medicare's upcoming weight-loss drug program could create major bottlenecks for doctors as millions of seniors seek access to popular GLP-1 treatments such as Wegovy and Zepbound. Clinicians are ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Weight loss drugs ...